Sl0043 50077 — New York, New York

Sl0043 50077 is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Sl0043 50077 has participated in 1 clinical trials.

Therapeutic areas: Systemic Lupus Erythematosus.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sl0043 50077?

Sl0043 50077 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sl0043 50077 conducted?

Sl0043 50077 has 1 clinical trials on record. Their work covers Systemic Lupus Erythematosus.

Is Sl0043 50077 accredited by Crixeo Health?

Sl0043 50077 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sl0043 50077?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.